This is a StreetInsider.com Premium Only Page

Cara Therapeutics (CARA) – Press Releases

Apr 2, 2024 07:00 AM Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

Mar 7, 2024 07:00 AM Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024

Mar 4, 2024 04:01 PM Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

Feb 12, 2024 04:01 PM Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024

Jan 22, 2024 07:00 AM Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026

Dec 18, 2023 07:00 AM Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis

Nov 13, 2023 04:01 PM Cara Therapeutics Reports Third Quarter 2023 Financial Results

Nov 2, 2023 07:00 AM Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty

Oct 23, 2023 07:00 AM Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023

Sep 25, 2023 07:00 AM Cara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients

Sep 5, 2023 07:00 AM Cara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 7, 2023 04:01 PM Cara Therapeutics Reports Second Quarter 2023 Financial Results

Aug 3, 2023 07:00 AM Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors

Aug 2, 2023 07:00 AM Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference

Jul 24, 2023 07:00 AM Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023

Jun 2, 2023 06:46 PM Palo Alto Networks Set to S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Jun 1, 2023 07:00 AM Cara Therapeutics to Present at the Jefferies Healthcare Conference

May 18, 2023 02:00 AM Kapruvia® (difelikefalin) recommended by England’s NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus

May 18, 2023 02:00 AM Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus

May 15, 2023 04:01 PM Cara Therapeutics Reports First Quarter 2023 Financial Results

May 1, 2023 07:00 AM Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023

May 1, 2023 07:00 AM Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023

Apr 10, 2023 07:00 AM Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference

Apr 10, 2023 07:00 AM Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference

Mar 14, 2023 07:00 AM Cara Therapeutics Releases Inaugural Environmental, Social, and Governance Report

Mar 14, 2023 07:00 AM Cara Therapeutics Releases Inaugural Environmental, Social, and Governance Report

Mar 6, 2023 04:01 PM Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results

Mar 6, 2023 04:01 PM Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results

Feb 21, 2023 07:00 AM Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023

Feb 21, 2023 07:00 AM Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023

Feb 8, 2023 05:00 PM Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine

Feb 8, 2023 05:00 PM Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine

Jan 17, 2023 07:00 AM Cara Therapeutics to Host Capital Markets Day on Thursday, February 16, 2023

Jan 17, 2023 07:00 AM Cara Therapeutics to Host Capital Markets Day on Thursday, February 16, 2023

Jan 3, 2023 07:00 AM Cara Therapeutics Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference

Jan 3, 2023 07:00 AM Cara Therapeutics Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference

Nov 29, 2022 07:30 AM KemPharm Announces Appointment of Christopher Posner as New Independent Director

Nov 7, 2022 04:01 PM Cara Therapeutics Reports Third Quarter 2022 Financial Results

Nov 7, 2022 04:01 PM Cara Therapeutics Reports Third Quarter 2022 Financial Results

Nov 3, 2022 07:00 AM Cara Therapeutics Announces Appointment of Lisa von Moltke, M.D., to its Board of Directors

Nov 3, 2022 07:00 AM Cara Therapeutics Announces Appointment of Lisa von Moltke, M.D., to its Board of Directors

Nov 2, 2022 07:00 AM Cara Therapeutics to Present at Upcoming Investor Conferences

Nov 2, 2022 07:00 AM Cara Therapeutics to Present at Upcoming Investor Conferences

Oct 24, 2022 07:00 AM Cara Therapeutics to Announce Third Quarter 2022 Financial Results on November 7, 2022

Oct 24, 2022 07:00 AM Cara Therapeutics to Announce Third Quarter 2022 Financial Results on November 7, 2022

Oct 10, 2022 04:05 PM SWK Holdings' Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics

Sep 28, 2022 07:00 AM Cara Therapeutics Announces Difelikefalin (KORSUVA®) Injection New Drug Application Has Been Submitted in Japan

Sep 28, 2022 07:00 AM Cara Therapeutics Announces Difelikefalin (KORSUVA®) Injection New Drug Application Has Been Submitted in Japan

Sep 12, 2022 07:00 AM Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer

Sep 12, 2022 07:00 AM Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer